Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue  by Cortés-Malagón, Enoc M. et al.
Gene expression proﬁle regulated by the HPV16 E7 oncoprotein
and estradiol in cervical tissue
Enoc M. Cortés-Malagón a,c, José Bonilla-Delgado c, José Díaz-Chávez d,
Alfredo Hidalgo-Miranda e, Sandra Romero-Cordoba e, Aykut Üren f, Haydar Çelik f,1,
Matthew McCormick f, José A. Munguía-Moreno a, Eloisa Ibarra-Sierra g,
Jaime Escobar-Herrera b, Paul F. Lambert h, Daniel Mendoza-Villanueva i,
Rosa M. Bermudez-Cruz a, Patricio Gariglio a,n
a Department of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados (Cinvestav), Mexico City 07360, Mexico
b Department of Cell Biology, Centro de Investigación y de Estudios Avanzados (Cinvestav), Mexico City 07360, Mexico
c Research Unit, Hospital Juárez de México, Mexico City 07760, Mexico
d Unit of Biomedical Research in Cancer, UNAM/Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico
e Oncogenomic Department,. Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City 14610, Mexico
f Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057-1469, USA
g Research Laboratory, Instituto Estatal de Cancerología, Acapulco 39570, Guerrero, Mexico
h McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA
i Laboratory of Cell and Developmental Signaling, National Cancer Institute-Frederick, PO Box B, Frederick, MD 21702-1201, USA
a r t i c l e i n f o
Article history:
Received 20 June 2013
Returned to author for revisions
15 July 2013
Accepted 30 August 2013
Available online 27 September 2013
Keywords:
HPV16 E7
17β-estradiol
Microarrays
Cervix
Carcinogenesis
K14E7
a b s t r a c t
The HPV16 E7 oncoprotein and 17β-estradiol are important factors for the induction of premalignant
lesions and cervical cancer. The study of these factors is crucial for a better understanding of cervical
tumorigenesis. Here, we assessed the global gene expression proﬁles induced by the HPV16 E7
oncoprotein and/or 17β-estradiol in cervical tissue of FvB and K14E7 transgenic mice. We found that
the most dramatic changes in gene expression occurred in K14E7 and FvB groups treated with 17β-
estradiol. A large number of differentially expressed genes involved in the immune response were
observed in 17β-estradiol treated groups. The E7 oncoprotein mainly affected the expression of genes
involved in cellular metabolism. Our microarray data also identiﬁed differentially expressed genes that
have not previously been reported in cervical cancer. The identiﬁcation of genes regulated by E7 and 17β-
estradiol, provides the basis for further studies on their role in cervical carcinogenesis.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Cervical cancer (CC), a worldwide health problem, has been
directly linked to genital infection by high-risk human papilloma-
viruses (HR-HPVs) (Munger et al., 2004). The HPV16 is the most
prevalent high-risk genotype in cervical carcinomas; it contains three
viral oncoproteins, E5, E6 and E7, which are involved in the induction
and maintenance of the transformed phenotype (Munger et al.,
2004). The HPV16 E7 is considered the major transforming protein
given its ability, in cell culture, to immortalize human epithelial cells
(Halbert et al., 1991), and, in the context of genetically engineered
mice expressing E7, to induce cervical tumors [in cooperation with
17β-estradiol (E2)] as well as to maintain precancerous lesions and
cancers once they have arisen (Arbeit et al., 1996; Jabbar et al., 2009;
Riley et al., 2003). E7's oncogenic potential is only partially attributed
to its inactivation of the retinoblastoma tumor suppressor protein
(pRb) (Darnell et al., 2007) given the observation that inactivation of
pRb is not sufﬁcient to explain all the oncogenic effects caused by E7
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(Balsitis et al., 2006). It is well documented that the transforming
activities of the E7 protein are related to the binding of a large
number of cellular targets (McLaughlin-Drubin and Munger, 2009).
In addition to the HR-HPV E7 oncoprotein, other factors are impor-
tant in cervical carcinogenesis.
Hormones, like E2, are conﬁrmed cofactors for HPV-related CC
(Gariglio et al., 2009). Important epidemiologic studies have indicated
the association between oral contraceptive intake and the risk of
developing both adenocarcinomas and squamous cell carcinomas
(Brisson et al., 1994; Moreno et al., 2002; Salazar et al., 2001). Riley
et al. have examined the relationship between E2, E6 or E7 oncopro-
teins and CC using 7-month-old transgenic mice expressing either E6
or E7 from HPV16 under the control of the human keratin 14
promoter (K14E6 or K14E7 mice, respectively). In this study they
treated mice with E2 for six months and then scored the severity of
cervical neoplasia. They found that E7 cooperates with E2 to induce
high-grade dysplasias, in situ carcinomas and microinvasive cancer,
whereas E6 had little effect in the development of CC (Riley et al.,
2003). This ﬁnding demonstrated that E7 is the most potent oncogene
in driving cervical carcinogenesis together with estrogen, but does not
discount a role of E6 in cervical cancer per se, as E6 does cooperate
with E2 to induce cervical cancer when K14E6 mice are treated with
estrogen for longer periods (Shai et al., 2007). Additionally, it has been
shown that E2 contributes not only to the onset, but also to the
persistence and malignant progression of CC in K14E7 transgenic
mice (Brake and Lambert, 2005) and interestingly, E2 fails to promote
either, dysplasia or CC in K14E7 mice lacking estrogen receptor
(Chung et al., 2008). These studies suggest that E2 has a prominent
effect in cell transformation and tumor development, and requires the
cooperation of the E7 protein during cervical carcinogenesis.
To identify genes regulated by HPV16 E7 and E2 that may play a
role in cervical carcinogenesis, the current study examines the global
changes in the pattern of gene expression from cervical tissue of 4-
month-old K14E7 transgenic and FvB mice treated with E2, as well as
untreated mice. Some of the genes identiﬁed in this study were
previously reported to be up- or down-regulated in CC, which validate
our transgenic model of carcinogenesis; however, the differential
expression of many other genes represents novel ﬁndings.
We found that immune response and metabolism are among
the biological processes most affected in the mouse cervix by
E2 and E7. These pathways likely represent early steps in E7 plus
E2-induced carcinogenesis. Their identiﬁcation as such provides
important new insights into the molecular mechanisms by which
HPV16 E7 and E2 contribute to the development of cervical cancer,
and open the possibility for new diagnostic markers of HPV-
associated carcinogenesis.
Results
Histological characterization of cervical premalignant lesions
To establish the dysplastic degree or cancer in the mouse cervix,
a “histopathological grading system for transgenic mouse cervical
squamous carcinogenesis” developed by Riley et al. (2003) was
performed (see “Materials and methods” section). Using cervical
slides from 4-month-old mice we observed squamous epithelial
hyperplasia, with an increase in the number of squamous epithelial
cell layers, occasional basal cell mitotic ﬁgures and preservation of
differentiated suprabasal keratinocytes in FvBþE2 mice (Fig. 1B). In
stark contrast, squamous cervical tissue from K14E7þE2 mice
contained cells with increased nuclear size, high degree of anapla-
sia, augmented frequency and distribution of dysplastic cells in the
suprabasal layers of the squamous epithelium, and the basal aspect
is projected into the cervical stroma (Fig. 1D); all above was
previously reported by Elson et al. (2000) and Arbeit et al. (1996)
as equivalent to human CIN2 lesions. Moreover, none of untreated
mice developed hyperplasia or neoplasia (Fig. 1A and C).
To compare the histopathological diagnosis and the expression
of established biomarkers for human cervical cancer (Branca et al.,
2007; Herbsleb et al., 2001; Middleton et al., 2003), immunohis-
tochemistry assays for PCNA and p16-INK4a were performed.
In K14E7þE2 mice, PCNA and p16-INK4a staining was mainly
nuclear, augmented and uniformly distributed through the full
thickness of the epithelium (Fig. 1H and L). This indicates a
generalized high-proliferative activity, similar to the staining
pattern that originates in the basal epithelial cells and extends to
the upper layers, usually observed in human CIN2 lesions (del Pino
et al., 2009; Dray et al., 2005; Kurshumliu et al., 2009; Missaoui
et al., 2010). On the contrary, in untreated K14E7 mice, PCNA
staining was restricted in its expression to basal and parabasal
compartments of the hyperproliferative stratiﬁed squamous
epithelium (Fig. 1G). Moreover, in the K14E7 mice p16-INK4a
staining was diffuse (Fig. 1K); however, the staining intensity
was lower than that observed in the K14E7þE2 mice (Fig. 1L). In
FvBþE2 mice, the expression of PCNA was only observed in the
basal layer (Fig. 1F); and p16-INK4a was expressed in basal and
suprabasal compartments (Fig. 1J). In FvB control mice the expres-
sion of PCNA and p16-INK4a was restricted to the basal compart-
ment of the stratiﬁed squamous epithelium (Fig. 1E and I).
Effect of the E7 oncoprotein and 17β-estradiol on the global
gene expression
In order to evaluate the global gene expression proﬁle in cervical
tissue induced by a combination of the E7 oncoprotein plus E2 or
HPV16-E7 oncoprotein and E2 alone, we used FvB and K14E7 female
mice treated with E2 pellets during three months and untreated
K14E7 mice, all of them compared with untreated FvB mice
(control). After the total RNA from cervix was extracted and
converted to cDNA, the groups were examined with Whole Mice
Genome Oligo Microarrays (See list of the differentially expressed
genes in GEO ID: GSE46890). Using ANOVA, a fold change criteria of
Z2 and r2, and a p-value o0.05, we determined that the most
dramatic changes in gene expression occur in the groups treated
with E2, independently if the strain corresponds to non-transgenic
or K14E7 (Fig. 2A). When comparing gene expression proﬁle among
K14E7þE2, K14E7 and FvBþE2 groups, we noted that several genes
were overlapped (Supplementary Table 1); therefore, a Venn dia-
gram (Fig. 2B) was constructed to identify common as well as
exclusively modulated genes by E7 oncoprotein and/or E2. The
comparison between K14E7þE2 and FvBþE2 yielded 70 overlap-
ping genes, 9 overlapping genes were found between K14E7þE2
and K14E7 and only 2 genes (Krtap3-3 and Serpinb3b) were
overlapped for all groups. Interestingly, 134 (K14E7þE2), 198
(FvBþE2) and 30 (K14E7) genes were exclusively regulated in each
group (Supplementary Tables 2–4) as compared to the control mice.
To classify differentially expressed genes involved in cellular
processes, we performed a Gene Ontology analysis using Ingenuity
Pathway (IPA) software. We observed that several processes
associated to immunity (cellular movement, hematological system
development, immune cell trafﬁc and inﬂammatory response)
were mainly modiﬁed in K14E7þE2 as well as in FvBþE2 mice
groups (Fig. 3); whereas carbohydrate metabolism, small molecule
biochemistry, lipid metabolism and molecular transport were the
most modiﬁed processes in the K14E7 mice.
Validation of the microarray data
To validate the microarray data, we selected genes involved in
different processes and in a variety of cancers. Five speciﬁc genes
that showed altered expression in K14E7þE2 (Il1a, Tnfa, Irf1,
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S100a8, and S100a9), ﬁve from K14E7 (Slc23a1, Iﬁ44, Gpd1,
Serpinb3b, and Spp1) and six genes from FvBþE2 (Il1a, Dmbt1,
Tnfa, Rerg, Tff1, and Igfbp5) were validated by real-time PCR
analysis. As shown in Fig. 4, the results for all the analyzed genes
were consistent with the microarray data. Among validated genes,
S100a8 and S100a9, members of the S100 protein family, were
the most up-regulated genes in K14E7þE2 group, whereas that
Slc23a1 was the most up-regulated and Gpd1 and Serpinb3b were
the most down-regulated in K14E7 group. Otherwise, in the
FvBþE2 animals an increased expression of Il1a and Dmbt1 genes
and decreased expression of the Tff1 were observed.
Estradiol enhances the S100a9 expression
It has been determined that the level of human protein S100-A9
is increased in many cancers and plays a key role in inﬂammation-
associated cancer (Markowitz and Carson, 2013) Since, in the
K14E7þE2 the S100a9 gene was one of the most up-regulated
genes, as determined by both microarrays and real time PCR, we
decided to determine mRNA and protein expression level in endo-
cervical epithelium from all experimental groups. Real time PCR and
Western blot analysis revealed extensive mRNA and protein expres-
sion of S100a9, respectively in FvBþE2 and K14E7þE2 groups
Fig. 1. Histopathology of mouse cervical tissue and biomarkers expression (PCNA and p16-INK4a). The images correspond to cross-sections of endocervical epithelium from
4-month-old nontransgenic (FvB) and HPV-transgenic mice (K14E7) untreated or treated with 17β-estradiol (E2) for 3 months. The sections were stained with H&E ((A)–(D))
and immunostained for PCNA ((E)–(H)) or p16-INK4a ((I)–(L)), as described under Materials and Methods. The brown signal represents positive cells for PCNA or p16-INK4a.
Visual ﬁeld at 40 magniﬁcation.
Fig. 2. Global expression proﬁle of K14E7þE2, K14E7 and FvBþE2 mice vs untreated FvB mice, respectively. To determine the differentially expressed genes, a fold change of
Z2 and r2, and a p-value cutoff of o0.05 were used. (A) 148, 16 and 197 up-regulated genes and 67, 25 and 73 down-regulated genes in K14E7þE2, K14E7 and FvBþE2
mice vs untreated FvB mice were detected, respectively. (B) The Venn diagram shows unique ((a)–(c)) and common ((d)–(g)) differentially expressed genes between the
K14E7þE2, K14E7 and FvBþE2 groups.
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(Fig. 5A and B). It is interesting to note that in untreated mice (K14E7
and FvB) the protein was not detected by Western blot. We also
evaluated the distribution and expression of protein S100-A9 in
cervical squamous tissue.
Immunohistochemical staining of cervical tissue sections from
E2 treated FvB and K14E7 mice revealed augmented expression of
the protein S100-A9; its expression was evident in the cytoplasm
and more intense in the nuclei of epithelial cells (Fig. 5C).
In untreated K14E7 mice, the expression and localization of this
protein was very similar to control FvB mice.
To corroborate the effect of HPV16 E7 oncoprotein and E2 on
human S100A9 gene expression, we utilized in vitro assays.
Human primary (HFK) and HPV16 E7 transformed keratinocytes
(HFK-E7) were cultured in keratinocyte serum free medium and
then treated with E2 or an estrogen antagonist (ICI 182,780).
We found that protein S100-A9 was drastically down-regulated
when the cells were treated with ICI 182,780 in comparison with
control cells (Fig. 5D). In contrast, the cells that were treated with
E2 showed a slight increase in the expression of protein S100-A9
(Fig. 5E). Additionally, the mRNA levels for S100A9 were measured,
but no signiﬁcant changes were observed between treated and
control cells (Data not shown). These results suggest that E2
induces the protein S100-A9 expression in vivo and in vitro.
Fig. 3. Gene ontology-based biological process pathways. For each experimental mice group, the genes were categorized into functional groups by the Ingenuity Pathway
Advanced (IPA) software. Closed bars indicate—log (p-value), which was calculated by the IPA software showing the levels of relatedness. The left Y-axis shows the—log
(p-value), and the X-axis indicates the name of functions.
Fig. 4. Validation of microarray data by RT-qPCR. Comparison of the expression levels of
selected genes determined by microarray analysis and real time PCR. All qPCR data were
normalized with Hprt as a housekeeping gene. The relative expression was determined
by 2ΔΔCt equation and the untreated FvB mice were used as a calibrator. The RT-qPCR
data are expressed as the means7SD of three independent analyses. Black bars
represent RT-qPCR values and gray bars represent microarray values.
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Estradiol and the HPV16 E7 oncoprotein have a signiﬁcant effect
on Claudin 4 expression
Given that the deregulation of the Cldn4 gene product has
recently been associated with epithelial cancers and the microarray
data of K14E7þE2 mice demonstrated that this gene was
up-regulated, we decided to determine the effect of the E7
oncoprotein and/or E2 on Cldn4 gene expression in mouse cervical
squamous tissue. We noted that mRNA expression was higher in
K14E7þE2 and FvBþE2 mice than in FvB control mice (Fig. 6A).
Moreover, in the K14E7 mice, the Cldn4 mRNA expression was very
similar to that of FvB control mice. To assess whether the changes
seen in mRNA expression of Cldn4 are also observed at the protein
level, Western blotting was carried out. The data show that the
Claudin-4 protein was increased by E7 and estradiol inﬂuence. It is
noteworthy that the mRNA and protein expression in FvBþE2 and
K14E7þE2 are correlated, but this was not observed for K14E7 mice
in which only a high level of Claudin-4 protein was detected
(Fig. 6B). The expression and distribution of Claudin-4 was also
detected by immunoﬂuorescence. Strikingly increased expression of
Claudin-4, delineating the cell borders in the suprabasal layer, was
detected in the cervical squamous tissue of the K14E7þE2 group
(Fig. 6C). In FvBþE2 the honeycomb pattern was similar to that seen
in FvB control; however, expression of Claudin-4 was signiﬁcantly
greater with E2 treatment. The Claudin-4 expression was also
enhanced in K14E7 mice, but the honeycomb pattern, observed in
the suprabasal layer, was diffuse. Interestingly, in the basal and
parabasal layers of FvB control and experimental groups Claudin-4
was absent. These results suggest that the E7 oncoprotein alone or
in conjunction with E2 enhance the expression of Claudin-4 only in
suprabasal layers of cervical epithelium.
Discussion
The molecular mechanisms by which the HPV16 E7 oncopro-
tein and the E2 contribute to the early stages of cervical carcino-
genesis remain unclear. We took a global approach to identify
potential mechanisms, by performing gene expression proﬁling of
cervical tissues from HPV16 E7 transgenic and nontransgenic mice
that had or had not been treated with estrogen. We found the
largest number of differentially expressed genes when comparing
E2-treated mice (K14E7þE2 or FvBþE2) to untreated mice (K14E7
and FvB). This could be partially explained because the estrogens
regulate the transcription of many genes through various mechan-
isms, such as (1) nuclear activation, including the classical inter-
action of the activated nuclear receptor with estrogen responsive
elements on the DNA; (2) effects through protein–protein inter-
actions with the Sp1, AP1, and NF-kB proteins (Nilsson et al., 2001),
and (3) non-nuclear effects through cell surface receptors linked to
the mitogen-activated protein kinase pathway (Gruber et al.,
2002). The E7 oncoprotein lacks intrinsic enzymatic and speciﬁc
DNA binding activities (Moody and Laimins, 2010), therefore its
ability to alter cellular gene expression must derive from its ability
to associate with and subvert the normal activities of cellular
regulatory complexes (Ghittoni et al., 2010; McLaughlin-Drubin
and Munger, 2009).
Due to the number of pathways affected by E7 and/or E2, it is
difﬁcult to discuss each in detail; therefore, we have chosen to
discuss the most altered processes in this K14E7 cervical cancer
model.
Many of the differentially expressed transcripts encode ele-
ments of the immune response, and many of such genes [Il1b, Il1a,
Tnfa, Il8rb, Tnfaip3, Cd74, Cd274, S100a8, S100a9, Ccl3, Cd14, Cd3g,
Fig. 5. The 17β-estradiol enhances the expression of S100-A9. Quantitative real-time PCR analysis showed a higher mRNA expression of S100a9 inK14E7þE2 and FvBþE2
mice compared to untreated mice (FvB or K14E7) (A). Bars (relative expression) represent the mean7SD of three independent experiments (npo0.05, nnpo0.01, Student's
t-test) normalized to Hprt mRNA and compared with the control (untreated FvB mice). Western blot analysis (B) and immunohistochemistry (C) also revealed a marked
up-regulated S100-A9 expression in K14E7þE2 and FvBþE2 mice. S100-A9 positive cells in immunohistochemistry show brown staining in the nucleus and cytoplasm. The
results show a representative of three experiments, nuclei were counterstained with hematoxylin and visual ﬁeld at 40 magniﬁcation. Western blot analysis of Human
primary and HPV16 E7 transformed keratinocytes treated with vehicle or ICI 182,780 (50 nM for 48 h) (D) and vehicle or E2 (10 nM) (E) for 24 h after 48 h starvation in the
absence of any growth factor. Cell fractionation was conducted, and lysates were subjected to SDS-PAGE followed by Western blot with anti-S100-A9 and anti-beta-actin
(control) antibodies. All gene and protein symbols were written according to the HUGO Gene Nomenclature Committee (HGNC) and UniProtKB, respectively.
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Cxcl13, H2-Q6, Iigp1, Inhba, Irg1, Tgtp, and Trem1 (see Supple-
mentary Table 1)] are expressed in common and with similar fold
change in both, K14E7 and FvB mice treated with E2. Previous
reports have demonstrated that some genes like Il1b (Polan et al.,
1988; Ruh et al., 1998), Tnfa, Tnfaip3 (Vendrell et al., 2007), Il8rb
(Cxcr2) (Lei et al., 2003) and S100a9 (Stygar et al., 2007) are
modulated by estrogen and its expression and secretion appears to
depend on the cell types, milieu conditions, and the estrogen
concentrations. Therefore, it is likely that in K14E7 mice treated
with E2, the expression of genes encoding components of the
immune response is primarily being modiﬁed by E2 rather than by
the E7 oncoprotein.
It is also interesting to note that some genes up-regulated by E2
mentioned above (Il1b, Tnfa, Cd74, Cd274, S100a8 and S100a9)
have been reported to be overexpressed in cervical cancer
(Al-Tahhan et al., 2011; Cheng et al., 2011a; Choi et al., 2007;
Karim et al., 2009; Manavi et al., 2007; Zhu et al., 2013). In these
studies, however, the inﬂuence of estrogens was not evaluated.
Some of the up-regulated genes that belong to the immune
response such as Ccl3, Cxcl13, Il8rb (Cxcr2) (expressed by both
the K14E7 and the FvB treated mice) have not been reported in
cervical cancer, but these genes have been reported to be up-
regulated in other cancers in which one ﬁnds inﬂammation. For
example, Ccl3, Cxcl13, Il8rb (Cxcr2) and Inhba over-expression has
been detected in oral squamous cell carcinoma (Silva et al., 2007),
breast epithelial tumor cells (Panse et al., 2008), gastric cancer
(Cheng et al., 2011b; Wang et al., 2012) and lung adenocarcinoma
(Seder et al., 2009), respectively. These results raise the possibility
that E2 may contribute to the differential expression of these genes
and therefore contribute to modulation of the inﬂammatory process
during cervical carcinogenesis in the K14E7þE2 mouse model.
Given the potential importance of immune responses and
inﬂammation in cancer, we decided to validate the expression of
one of the inﬂammation-associated genes, S100-A9, a calcium-
and zinc-binding protein that belongs to the S100/calgranulins
family and is found mainly in a variety of immune cells as well as
in squamous epithelium. Human protein S100-A9 has antimicro-
bial, cytostatic, antiproliferative, apoptosis-inducing and chemo-
tactic properties (Srikrishna, 2012). In the present study, we found
overexpression of S100a9 gene in the E2-treated mice groups at
both the mRNA and the protein level. In HFK cells, the treatment
with an estrogen antagonist decreased drastically the level of
S100-A9 protein, in agreement with our results in the mouse
model, suggesting that E2 could be involved in the up-regulation of
S100a9 in vivo.
This gene may be responding indirectly to E2, through inﬂam-
matory stimuli such as Interleukin-1 beta (Bando et al., 2007) or
tumor necrosis factor (Hiratsuka et al., 2006) which promote the
expression and the formation of protease-resistant S100-A9
homodimers (Riva et al., 2013). In this context, it is interesting to
note that Il1b and Tnfa genes were found up-regulated in the E2
treated groups; therefore, these cytokines may be directly regulat-
ing the expression of S100a9 in the cervix.
Recently, protein S100-A9 over-expression has been reported in
CIN 1, CIN 2, CIN 3 and squamous cervical cancer (Zhu et al., 2013,
2009). In other tumors it has been associated with development,
invasion or metastasis (Ichikawa et al., 2011; Kallberg et al., 2012;
Li et al., 2012). There are also reports that suggest that the complex
S100A8/A9 induces apoptosis and inhibits metastasis in the CaSki
cell line, and also reduces cell growth in other cell lines derived
from cervical cancer (Qin et al., 2010; Tugizov et al., 2005);
however, these effects have not yet been established in vivo.
A second set of genes we found altered in their expression are
involved in metabolism, such as Ucp1, Cox7a1 and Cox8b, which
were down-regulated in K14E7 and K14E7þE2 mice. The Ucp1
protein product, which is located in the mitochondria of brown
Fig. 6. Effect of HPV16-E7 and/or 17β-estradiol on the expression of Cldn4. Real time PCR (A) and Western blotting (B) analysis showed an increased expression of the Cldn4
gene in treated mice (K14E7þE2 and FvBþE2), as well as in K14E7 mice compared with the untreated control (FvB). Immunoﬂuorescence with an antibody against Claudin-4
(C) also showed a higher level of Claudin-4 protein in K14E7þE2 and FvBþE2 mice vs untreated FvB mice; in untreated K14E7 mice Claudin-4 was distributed diffusely
throughout the plasma membrane (green). Proliferative and non-proliferative cells are shown as pink and blue signal, respectively. For RT-qPCR and Western blot, bars
represent the mean7SD of three independent experiments (npo0.05, nnpo0.01, Student's t-test). Data were normalized to Hprt and compared with the control. Visual ﬁeld
at 40 magniﬁcation.
E.M. Cortés-Malagón et al. / Virology 447 (2013) 155–165160
adipocytes, acts as a proton carrier activated by free fatty acids and
enhances respiration and cellular heat production (Mailloux and
Harper, 2011). Over-expression of Ucp1 results in an increased
oxygen consumption and decreased tumor growth (Chen et al.,
2009; Lee et al., 2012). Ucp3 (a homologous to Ucp1), also
increases the mitochondrial respiration and is associated with
resistance to chemically-mediated multistage skin carcinogenesis
(Lago et al., 2012). Other genes reduced in their expression in E7
transgenic mice that also participate in the respiratory chain are
Cox7a1 and Cox8b, subunits of cytochrome C oxidase (COX).
Suppression of mitochondrial respiration and COX activity (by
inhibiting the expression of COX6C, COX7A, and COX7C subunits),
as well as the induction of the glycolytic switch are mediated by
induction of the Wnt pathway (Lee et al., 2012). These ﬁndings
suggest that in our mice models (K14E7þE2 and K14E7), the
down-regulation of Ucp1, Cox7a1 and Cox8b might decrease
mitochondrial respiration, promote the glycolytic activity and
increase tumor growth.
It is known that HPV16 E7 perturbs the keratinocytes differ-
entiation program and allow DNA synthesis to occur in a subset of
suprabasal cells of the cervical epithelial tissue (Flores et al., 2000).
In agreement with this issue, we noted that PCNA, a marker of
non-differentiated proliferative cells, is markedly increased by the
E7 oncoprotein (K14E7þE2 and K14E7 mice) in the basal and
suprabasal compartments of the cervical tissue; besides, it is
interesting to note that a cluster of keratinocyte differentiation-
related genes (late corniﬁed envelope genes, precursors of the
corniﬁed envelope of the stratum corneum) were signiﬁcantly
down-regulated in K14E7 and K14E7þE2 mice. These ﬁndings
conﬁrm and extend the previous observations that genes involved
in epithelial differentiation are down-regulated by HPV16 E7
expression, uncoupling the proliferation and differentiation pro-
cesses (Gyongyosi et al., 2012; Santin et al., 2005).
We cannot rule out the possibility that changes in gene
expression do not represent direct effects of E7 and/or estrogen,
but rather indirect effects that reﬂect expansion of cells popula-
tions that remain proliferatively active and/or resistant to terminal
differentiation. For example, HPV16 E7 and estradiol stimulate the
production of cytokines like Il1a (previously mentioned) which in
turn induces expression of polypeptide growth factors that stimu-
late proliferation of normal keratinocytes and carcinoma cells
through autocrine and paracrine pathways (Bando et al., 2007;
Castrilli et al., 1997). Also, it is not known that the E7 oncoprotein
and estradiol regulate directly the expression of late corniﬁed
envelope genes, precursors of the corniﬁed envelope of the
stratum corneum (discussed above). These changes may reﬂect
secondary effects of these factors.
Another up-regulated gene in K14E7þE2 mice was Cldn4.
Claudin-4 is a component of tight junctions, which plays an
important role in tumor cell invasion and metastasis (Shang
et al., 2012). The tight junction proteins have been shown to be
deregulated in a number of epithelial cancers. Whereas the
expression of Claudin proteins is up-regulated in certain cancers
including prostate cancer (Long et al., 2001) and pancreatic cancer
(Nichols et al., 2004), Claudin proteins can also be down-regulated
in other cancers such as head and neck cancer (Al Moustafa et al.,
2002) and breast cancer (Kominsky et al., 2003). Moreover, over-
expression of Claudin 3 and Claudin 4 both at the mRNA and
protein levels has been observed in ovarian cancer (Agarwal et al.,
2005). Forced expression of Claudin-4, in cells that do not
normally express Claudin-4, increased cell motility. Recently, it
has been shown that Claudin-4 can also promote motility in cells
that normally express Claudin-4 and that both normal cells and
different types of tumor cells exhibit the same phenomenon
(Webb et al., 2013). These studies have led to the suggestion
that Claudin proteins, either alone or in combination with other
proteins, may represent useful biomarkers for the detection and
diagnosis of certain cancers (Agarwal et al., 2005). In the present
study we learned that HPV16 E7 and/or E2 increased Claudin-4
expression. Interestingly, we observed that this overexpression is
limited to the suprabasal cells of stratiﬁed epithelium (see Fig. 6C).
These results are consistent with another report that found the
expression of Claudin-4 was exclusively in suprabasal layers of CIN
lesions (Sobel et al., 2005). These data denoted a disturbance in
cell proliferation and differentiation, so the Claudin-4 overexpres-
sion could be an important marker of the interruption of normal
differentiation and an early marker in cervical cancer.
We recognize that we are unable to strictly associate the observed
changes in gene expression to a particular cell type. However, we
found that data obtained from certain genes, such as Claudins (e.g.
Cldn4) (Morin, 2005; Tsukita and Furuse, 2002) will likely agree with
those of microdissected epithelium due to their preferential expres-
sion in epithelial cells. As a support of this observation, many genes
analyzed in our work (see Supplementary Table 5) have been
reported with similar expression proﬁle in microdissected high-
grade squamous intraepithelial lesions and cervical squamous cell
carcinomas (Gius et al., 2007; Zhai et al., 2007). Only two genes
differentially expressed in stromal tissue (Arhgdib, Igfbp5) were
matched in our work (Gius et al., 2007). Therefore, the study of
HPV16 E7 oncoprotein, estradiol, or a combination of both factors in
the entire cervix might provide information similar to those of
microdissected tissue, which may cooperate during cervical carcino-
genesis. In this regard, it is relevant to note that we recently
determined that the effects of estrogen on cervical carcinogenesis
are mediated at least in part by estrogen/estrogen receptor
α-mediated signaling within the cervical stroma (Chung et al., 2013).
In summary, the results presented here suggest that the HPV16
E7 oncoprotein mainly contribute to cervical carcinogenesis by
editing the metabolism and E2 mainly modiﬁed processes asso-
ciated to immunity. It is important to note that we also identiﬁed a
number of aberrantly regulated genes previously reported to be
involved in the pathogenesis of cervical cancer. In addition, we
identiﬁed new genes which could play a role in the cervical
tumorigenesis and might offer the potential of developing new
diagnostic markers and therapeutic targets.
Materials and methods
Mouse models and hormone treatment
The K14E7 and FvB mice have been described previously (Riley
et al., 2003). All the mice were housed and treated according to the
American Association of Laboratory Animal Care (AALAC), and all
experiments and procedures were approved by the Research Unit
for Laboratory Animal Care Committee (UPEAL-CINVESTAV-IPN,
Mexico; NOM-062-ZOO-1999). Hormone treatment was carried
out for three months with E2 pellets, one-month virgin female
transgenic and nontransgenic mice were implanted in the dorsal
skin with continuous release pellets delivering 0.05 mg of E2 over
60 days (Innovative Research of America). To complete the treat-
ment two pellets were used and then the mice were sacriﬁced to
4-month-old. We also used K14E7 and FvB (control) untreated
mice of the same age.
Tissue procurement and histopathology
K14E7 hemizygote and nontransgenic FvB control virgin female
untreated and treated mice were sacriﬁced by cervical dislocation.
All specimens were formalin-ﬁxed and parafﬁn embedded. Sec-
tions were deparafﬁnized and rehydrated as described previously
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(Ibarra Sierra et al., 2012). Serial sections were cut (5 mm thick) and
stained with H&E (haematoxylin and eosin).
A histopathological grading system for transgenic mouse cer-
vical squamous carcinogenesis developed by Riley et al. was used
to classify histological samples. Using this mouse cervical neopla-
sia grading system, CIN1 consists of a 2-fold increase in the basal/
basaloid cell layers of cervical and vaginal squamous epithelia of
transgenic compared with estrogen-treated nontransgenic mice.
CIN2 lesions contain cells with additional increases in nuclear size,
degree of anaplasia, frequency, and distribution of dysplastic cells
in the suprabasal layers of the squamous epithelium. Moreover,
the basal aspect of the squamous epithelium is projected into
papillary folds projecting into the underlying vaginal or cervical
stroma. CIN3 lesions contain abundant anaplastic cells, some with
pronounced increases in nuclear size. CIS demonstrates a pro-
nounced degree of remodeling and undulation of the epithelial–
stromal border and most of the cellular features of well-
differentiated squamous carcinoma, with retention of an intact
basement membrane without evidence of microinvasion on serial
sections.
Microarray sample processing
K14E7 hemizygote and nontransgenic FvB control virgin female
untreated and treated mice were sacriﬁced by cervical dislocation.
Cervical biopsies were immediately stored in RNA later Solution
(Ambion) at 4 1C overnight. Tissue was recovered from RNA later
solution with sterile forceps, quickly blotted to remove excess RNA
later and immediately snap frozen in liquid nitrogen. Total RNA was
extracted from snap frozen tissue using standard procedures (TRIzol
reagent, Ambion). Total RNA collected from nine female mice of
each group was extracted. RNA quantity and quality were assessed
on an Agilent 2100 Bioanalyzer (Agilent Technologies). Only RNA
samples with a RNA Integrity Number greater than 8.0 were further
processed for microarray analysis. cDNA synthesis, ampliﬁcation,
and gene expression proﬁling were performed according to the
manufacturer's instructions (Affymetrix WT Sense Target labeling
assay Manual). The RNA from three different mice was pooled and
three independents pools were used by each group. Each micro-
array experiment was performed as biological triplicates for each
group using GeneChip Mouse Gene 1.0 ST Array.
Analysis array data
Signal intensities from each array were analyzed using Partek
Genomic Suite version 6.4 (Partek). Raw intensity probe values
were normalized using robust multiarray analysis background
correction (RMA). A two way ANOVA was performed to identify
differentially expressed genes. Only genes with statistically
signiﬁcant differences in expression levels (p-value o0.05) and a
fold change criteria of Z2 and r2 were included in the ﬁnal set
of differentially expressed genes. The microarray data were
deposited to the NCBIGEO database [GEOID: GSE46890]. To iden-
tify those biological processes altered by E7 and/or E2, we used
Ingenuity Pathway software (Ingenuity Systems), a bioinformatic
tool for visualizing expression data in the context of KEGG-deﬁned
biological pathways. All human and mouse gene and protein
symbols were written according the HUGO Gene Nomenclature
Committee (HGNC) and UniProtKB, respectively.
Relative mRNA quantiﬁcation by real-time quantitative PCR and data
analysis using the 2ΔΔCt method
Isolated RNA from six mice from each group (K14E7, FvB,
K14E7þE2 and FvBþE2) was puriﬁed and its quality determined
by electrophoresis on a 2% agarose gel and visualization of
ribosomal RNA by ethidium bromide staining. RNA was quantiﬁed
by spectrophotometric analysis at 260 nm and 280 nm. cDNA
synthesis was done as described according to manufacturer's
instructions (Invitrogen). Quantitative real-time PCR (RT-qPCR)
was carried out using a LightCycler 2.0 apparatus (Roche) and a
DNA Master SYBR Green I kit (Roche). The templates were
ampliﬁed in 45 cycles of a 3-step PCR process, which included
30 s of denaturation step at 95 1C, a 30-s primer-dependent
annealing phase (60 1C), and a 30-s template-dependent elonga-
tion at 72 1C. Each gene-speciﬁc RNAwas quantiﬁed in triplicate by
real time PCR and mRNA ratios relative to the house-keeping gene
HPRT were calculated for standardization of gene expression levels
across samples using the Ct method. All primer sequences and
product size are described in Table 1
Immunochemistry and immunoﬂuorescence procedures
The cervical sections were processed for immunohistochemical
staining. The protein detection for immunohistochemistry was
conducted using the Mouse/Rabbit PolyDetector HRP/DAB Detec-
tion System (Bio SB) according to manufacturer's recommenda-
tions and HPR conjugated anti-rat antibody. The samples were
incubated overnight with primary antibodies against PCNA, p16-
INK4a, (Santa Cruz Biotechnology) Claudin-4 (Invitrogen) or pro-
tein S100-A9 (Abcam). Anti-rat HPR conjugated was used as
secondary antibody for detection of protein S100-A9 antibody.
Following the immunohistochemical procedures, the tissues were
counterstained with hematoxylin and mounted in GVA-mount
reagent (Zymed). For the immunoﬂuorescence procedures, the
cervical sections were rinsed in 1 PBS and blocked for 2 h at 4 1C
with 1 PBS that was supplemented with 0.3% Triton X-100 and
1% bovine serum albumin; they were washed three times with
1 PBS and incubated for 1 h at 37 1C with an anti-Claudin
4 antibody (Santa Cruz Biotechnology). The sections were then
incubated with a ﬂuorescein isothiocyanate (FITC)-labeled second-
ary antibody (Zymed) for 30 min at room temperature; they were
rinsed above, counterstained with propidium iodide, and mounted
in Vectashield (Vector). The preparations were examined by
confocal microscopy using an SP2 (Leica Microsystems). Captured
images were imported into Adobe Photoshop CS6 (Adobe Systems)
to produce maximum projections.
Cell culture
Human foreskin primary and HPV16 E7 transformed keratino-
cytes were cultured in keratinocyte serum free medium containing
recombinant epidermal growth factor and bovine pituitary extract
as supplements (Gibco, Life Technologies).
Western blot
The whole cervices were subjected to total protein extraction
and 20 mg were used to SDS-PAGE and transferred to an Immobilon-
P membrane (Millipore). The membrane was blocked in 5% nonfat
dry milk in 1 TBS (20 mmol/L Tris–HCl, pH 7.5, 150 mmol/L NaCl,
and 0.5% Tween-20) for 1 h, blotted with an anti-S100-A9 (1:2000)
or anti-Claudin-4 (1:1000) primary antibodies overnight, and then
incubated with a horseradish peroxidase (HRP)-linked anti-rat or
anti-rabbit secondary antibody (GE Healthcare) for 1 h. The mem-
branes were developed using the Millipore Immobilon Western
Chemiluminescent HRP Substrate according to the manufacturer's
instructions. Chemiluminescence was detected using a FujiFilm
LAS-3000 imaging system.
Human foreskin primary and HPV16 E7 transformed keratino-
cytes were treated with vehicle (0.5% ethanol) or 50 nM ICI
182,780 (Tocris Bioscience) for 48 h. ICI 182,780 stock solution
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was prepared by dissolving in ethanol at a 10 μM concentration.
For β-estradiol treatment, cells were ﬁrst serum starved for 48 h,
then treated with β-estradiol (10 nM) for 24 h. Water-soluble 17-β
estradiol (Sigma-Aldrich) was prepared fresh by dissolving in
keratinocyte serum free medium as a 10 mM stock solution
(106 fold). Western blot analysis was performed under conven-
tional conditions. Cells grown to 80% conﬂuency were lysed with
cell lysis buffer (1% Triton X-100, 100 mM NaCl, 50 mM HEPES,
pH 7.9, 10 mM EDTA, 4 mM NaPP, 10 mM NaF, 2 mM vanadate,
1 mM PMSF, 2 μg/mL aprotinin and 2 μg/mL leupeptin). Total
protein (50 μg) was loaded into each well, resolved by 12% SDS-
polyacrylamide gel electrophoresis (PAGE), and then electro-
blotted onto Immobilon-P membrane (Millipore). Anti-hS100A9
(B-5) (Santa Cruz Biotechnology) antibody (1:300) was added to
the membrane in 5% nonfat dry milk in 1 TTBS for 2 h. The
membrane was then washed three times in 1 TTBS and HRP-
linked anti-mouse secondary antibody (GE Healthcare) was added
for 1 h. Actin HRP-linked primary antibody (Santa Cruz Biotech-
nology) was utilized as a control. Blots were washed three times in
1 TTBS and then developed using Millipore Immobilon Western
Chemiluminescent HRP Substrate per the manufacturer's instruc-
tions (Millipore). Chemiluminescence was detected using a Fuji-
ﬁlm LAS-3000 imaging system.
Statistical analysis
For all data comparison, the Student's t-test was performed using
Microsoft Excel. A p value of o0.05 was considered statistically
signiﬁcant.
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